Complete short-term correction of canine hemophilia A by in vivo gene therapy.

Abstract excerpt

Hemophilia A is a severe bleeding disorder caused by a deficiency in clotting factor VIII (FVIII). A canine model that closely mimics the human disease was used to determine if an adenoviral vector expressing a human FVIII cDNA could be used to correct the hemophilia A phenotype. Within 48 hours after peripheral vein administration of the vector to FVIII-deficient dogs, the hemophilic phenotype was corrected,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoviridae
• Share to Dogs
• Share to Factor VIII